- Country: Sri Lanka
- Summary: Dicobalt Edetate Injection 300mg 20ml ampoule Dicobalt Edetate Injection 300mg 20ml Ampoule Each 20ml ampoule to contain 300mg of Dicobolt Edetate for intravenous use.
- LKT Ref No: 114773570
- Deadline: 25 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: DHS/P/WW/15/26
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- tenders are invited for, Dicobalt Edetate Injection 300mg 20ml ampoule Dicobalt Edetate Injection 300mg 20ml Ampoule Each 20ml ampoule to contain 300mg of Dicobolt Edetate for intravenous use.
- Documents:
dhspww1526-67ad92a58cbed7.36193596.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDicobalt Edetate Injection 300mg 20ml ampoule Dicobalt Edetate Injection 300mg 20ml Ampoule Each 20ml ampoule to contain 300mg of Dicobolt Edetate for intravenous use. - Srilanka Tender
The STATE PHARMACEUTICALS CORPORATION OF SRI LANKA, a Government sector organization in Sri Lanka, has announced a new tender for Dicobalt Edetate Injection 300mg 20ml ampoule Dicobalt Edetate Injection 300mg 20ml Ampoule Each 20ml ampoule to contain 300mg of Dicobolt Edetate for intravenous use.. This tender is published on SrilankaTender under LKT Ref No: 114773570 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-25.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
